Chronic Wound Care Management and Research最新文献

{"title":"Polyurethane film dressings and ceramide 2-containing hydrocolloid dressing reduce the risk of pressure ulcer development in high-risk patients undergoing surgery: a matched case-control study","authors":"M. Kohta, Kazumi Sakamoto, T. Oh‐i","doi":"10.2147/CWCMR.S77087","DOIUrl":"https://doi.org/10.2147/CWCMR.S77087","url":null,"abstract":"pBackground: Numerous clinical challenges regarding adhesive dressings have shown that using an adhesive dressing could minimize or prevent superficial skin loss in patients at risk of developing pressure ulcers. However, evidence that polyurethane film dressings and ceramide 2-containing hydrocolloid dressing can reduce the risk of pressure ulcer development in highrisk patients undergoing surgery is limited. Therefore, we assessed the effects of application of these dressings for reducing the risk of pressure ulcer development in these patients and identified other risk factors. Methods: A matched case-control study was conducted involving 254 patients at high risk for pressure ulcer development at one acute care hospital in Japan. No patients in this study had a pressure ulcer at the start of the study. Thirty-one patients developed a pressure ulcer during surgery, and these patients were defined as cases. Controls were randomly matched for sex and age (±4 years), from which 62 patients were selected. Medical records were obtained for preoperative factors, including age, sex, body mass index, diabetes mellitus, albumin, total protein, C-reactive protein, white cell count, red cell count, and hemoglobin, and for intraoperative factors, including dressing application, operation time, body position, and surgery type. The odds ratio (OR) and 95% confidence interval (CI) were determined to identify risk factors for pressure ulcer development in patients undergoing surgery. Results: By multiple logistic regression analysis, there was a significantly reduced risk of pres sure ulcer development for patients who had dressing applications as compared with those without dressing applications (OR 0.063; 95% CI 0.012–0.343; P=0.001). Prone position (OR 8.791; 95% CI 1.630–47.400; P=0.01), prolonged operation time (OR 1.684; 95% CI 1.189–2.385, P=0.003), and reduced body mass index (OR 0.774; 95% CI 0.584–0.948; P=0.02) were also significant predictive risk factors for development of a pressure ulcer. Conclusion: Application of film dressing and ceramide 2-containing hydrocolloid dressing reduced the risk of pressure ulcer development in high-risk patients undergoing surgery.","PeriodicalId":43306,"journal":{"name":"Chronic Wound Care Management and Research","volume":"2 1","pages":"23-30"},"PeriodicalIF":2.1,"publicationDate":"2015-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/CWCMR.S77087","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68337434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Compression therapies for chronic venous leg ulcers: interventions and adherence","authors":"C. Latz, K. Brown, R. Bush","doi":"10.2147/CWCMR.S62940","DOIUrl":"https://doi.org/10.2147/CWCMR.S62940","url":null,"abstract":"Compression therapy has been the mainstay for the treatment of lower extremity edema, venous insufficiency, and particularly, venous ulcerative disease. Though modern surgical treatments exist, none are completely effective without good compressive options to allow for decreased swelling and better oxygenation of damaged tissues. This review article will describe the pathophysiology and presentation of lower extremity venous ulcerations, as well as current options for compression therapy. The benefits, along with the major pitfall of nonadherence, will also be discussed.","PeriodicalId":43306,"journal":{"name":"Chronic Wound Care Management and Research","volume":"2 1","pages":"11-21"},"PeriodicalIF":2.1,"publicationDate":"2015-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/CWCMR.S62940","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68336674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Amniotic membrane allografts: development and clinical utility in ophthalmology","authors":"A. Rizzuti, Adam A. Goldenberg, D. Lazzaro","doi":"10.2147/CWCMR.S50955","DOIUrl":"https://doi.org/10.2147/CWCMR.S50955","url":null,"abstract":"Amniotic membrane, the innermost layer of the placenta, is a tissue that promotes epithelialization, while decreasing inflammation, neovascularization, and scarring. It is used in the surgical management of a wide variety of ophthalmic conditions where it functions as a graft or patch in ocular surface reconstruction. The development of new preservation techniques, as well as a sutureless amniotic membrane, has allowed for easier, in-office placement, without the disadvantages of an operating room procedure. The purpose of this review is to describe the historical development of amniotic membrane in ophthalmology and to describe its current clinical applications, particularly focusing on recent advances.","PeriodicalId":43306,"journal":{"name":"Chronic Wound Care Management and Research","volume":"1 1","pages":"67-72"},"PeriodicalIF":2.1,"publicationDate":"2014-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/CWCMR.S50955","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68335757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Biologic mesh for abdominal wall reconstruction","authors":"Kathryn S. King, F. Albino, P. Bhanot","doi":"10.2147/CWCMR.S58816","DOIUrl":"https://doi.org/10.2147/CWCMR.S58816","url":null,"abstract":"Background: Mesh reinforcement significantly decreases rates of recurrence following ventral hernia repair. Historically, biologic mesh was touted as superior in the setting of infection; however, selecting the appropriate mesh for a given clinical scenario is often a matter of debate. The purpose of this review is to highlight a number of the more commonly used biologic mesh products with a review of outcomes from the current literature. Methods: Outcomes following abdominal wall reconstruction using biologic mesh were reviewed for acellular cadaveric human dermis, cross-linked porcine dermis, non-cross-linked porcine dermis, porcine small intestine submucosa, acellular bovine pericardial, and acellular bovine dermal mesh. Studies with rigorous methods, adequate patient samples, and sufficient follow-up were selected for review. Results: Hernia recurrence rates following biologic mesh reinforcement vary widely. Porcine small intestine submucosa and bovine pericardium were associated with the lowest hernia recurrence rates. Porcine cross-linked dermal mesh products resulted in higher rates of adhesion formation and lower rates of tissue incorporation compared to non-cross-linked porcine mesh. Conclusion: Successful ventral hernia repair can be achieved with acceptable complications rates for each of the reviewed mesh products. Biologic meshes have an advantage over synthetic mesh in contaminated wounds but their use may not be cost-effective in all patient populations. Those with and/or at high risk for wound complications may also undergo repair with biologic mesh.","PeriodicalId":43306,"journal":{"name":"Chronic Wound Care Management and Research","volume":"72 1","pages":"57-65"},"PeriodicalIF":2.1,"publicationDate":"2014-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/CWCMR.S58816","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68335816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pressure ulcer treatment in a long-term care setting: wound bed healing with clostridial collagenase ointment versus hydrogel dressing","authors":"C. Waycaster, A. Gilligan, C. Milne","doi":"10.2147/CWCMR.S68930","DOIUrl":"https://doi.org/10.2147/CWCMR.S68930","url":null,"abstract":"License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Chronic Wound Care Management and Research 2014:1 49–56 Chronic Wound Care Management and Research Dovepress","PeriodicalId":43306,"journal":{"name":"Chronic Wound Care Management and Research","volume":"1 1","pages":"49-56"},"PeriodicalIF":2.1,"publicationDate":"2014-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/CWCMR.S68930","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68337030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk assessment tool for incontinence-associated dermatitis in elderly patients combining tissue tolerance and perineal environment predictors: a prospective clinical study","authors":"Yoshie Ichikawa-Shigeta, H. Sanada, C. Konya, S. Yusuf, Supriadi, J. Sugama","doi":"10.2147/CWCMR.S71122","DOIUrl":"https://doi.org/10.2147/CWCMR.S71122","url":null,"abstract":"(unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Chronic Wound Care Management and Research 2014:1 41–47 Chronic Wound Care Management and Research Dovepress","PeriodicalId":43306,"journal":{"name":"Chronic Wound Care Management and Research","volume":"1 1","pages":"41-47"},"PeriodicalIF":2.1,"publicationDate":"2014-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/CWCMR.S71122","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68336691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A new generation of topical chronic wound treatments containing specific MMP inhibitors","authors":"R. Shrivastava, Nathalie Cucuat, M. Rousse, Thomas Weigand, P. Neto, C. Janicot, C. Shrivastava","doi":"10.2147/CWCMR.S59946","DOIUrl":"https://doi.org/10.2147/CWCMR.S59946","url":null,"abstract":"License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Chronic Wound Care Management and Research 2014:1 31–40 Chronic Wound Care Management and Research Dovepress","PeriodicalId":43306,"journal":{"name":"Chronic Wound Care Management and Research","volume":"1 1","pages":"31-40"},"PeriodicalIF":2.1,"publicationDate":"2014-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/CWCMR.S59946","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68335860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Objective evaluation for venous leg ulcer-related nociceptive pain using thermography","authors":"T. Goto, A. Naito, Nao Tamai, G. Nakagami, M. Mo, H. Sanada","doi":"10.2147/CWCMR.S67054","DOIUrl":"https://doi.org/10.2147/CWCMR.S67054","url":null,"abstract":"License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Chronic Wound Care Management and Research 2014:1 23–30 Chronic Wound Care Management and Research Dovepress","PeriodicalId":43306,"journal":{"name":"Chronic Wound Care Management and Research","volume":"1 1","pages":"23-30"},"PeriodicalIF":2.1,"publicationDate":"2014-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/CWCMR.S67054","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68336960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Honey as an effective antimicrobial treatment for chronic wounds: is there a place for it in modern medicine?","authors":"R. Cooper","doi":"10.2147/CWCMR.S46520","DOIUrl":"https://doi.org/10.2147/CWCMR.S46520","url":null,"abstract":"Honey has a long history in the treatment of wounds, where claims of its therapeutic properties include the inhibition of a wide range of infectious agents as well as an ability to promote rapid wound healing. However, honey is not a uniform product, and its chemical composition can be influenced by multiple factors. The availability of modern, licensed dress - ings containing medical grade honey has garnered renewed interest in its clinical potential for conventional wound care. Laboratory investigations are beginning to explain at a cellular and molecular level the effects of specific honeys on certain microorganisms, but the clinical evidence of its antimicrobial effects is limited at present. The aim of this review is to demonstrate the chemical complexity of honey, to describe the mechanisms of antibacterial action reported to date, and to collate the evidence that provides insight into antimicrobial claims for honey.","PeriodicalId":43306,"journal":{"name":"Chronic Wound Care Management and Research","volume":"1 1","pages":"15-22"},"PeriodicalIF":2.1,"publicationDate":"2014-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/CWCMR.S46520","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68336127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety and efficacy of Becaplermin gel in the treatment of diabetic foot ulcers","authors":"P. Blume, Melinda A. Bowlby, Brian M. Schmidt, Ryan J Donegan","doi":"10.2147/CWCMR.S64905","DOIUrl":"https://doi.org/10.2147/CWCMR.S64905","url":null,"abstract":": Becaplermin gel remains the only US Food and Drug Administration (FDA)-approved growth factor for the treatment of diabetic neuropathic foot ulcers. Becaplermin gel has shown to be efficacious in a number of clinical trials. The FDA has added a black box warning label about the risk of cancer associated with the use of three or more Becaplermin tubes. Other adverse drug reactions associated with Becaplermin gel use are minimal. There is a need for further research regarding the true correlation between cancer and Becaplermin gel use.","PeriodicalId":43306,"journal":{"name":"Chronic Wound Care Management and Research","volume":"1 1","pages":"11-14"},"PeriodicalIF":2.1,"publicationDate":"2014-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/CWCMR.S64905","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68336861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}